.Merck defeats revenues expectations, raises purchases outlook on powerful demand for best drugs like Keytruda CNBCMerck & Co. (MRK United States) Trumps Earnings Forecasts as Keytruda Purchases Growth BloombergMerck Sell: Pharma Giant Posts Solid Results, However Outlook Drops Short Entrepreneur's Service DailyMerck Announces Second-Quarter 2024 Financial Results Yahoo FinanceMerck trumps revenue and also sales expectations amidst Keytruda strength, but provides blended full-year overview MarketWatch.